The acceptance of the solid-phase format in various areas of clinical chemistry is the consequence of the advantages of this test format, which include stability of the reagents, unitized packaging, convenient and small instruments, and minimal preparations by users before testing. Overall, these advantages provide very convenient tests. Future successful uses of solid-phase reagents depend upon how well these features meet the needs of the users. Needs for systems to be used in the decentralized laboratory include even less cost, even more convenience, and improved quality control. Needs for home testing include convenient tests with clinically useful accuracy, improved quality control, and improved recording systems to overcome user bias in recording results. New solid-phase technologies being developed include noncolonmetric systems suitable for use with miniature probes, for in vitro or in vivo use, and spectrophotometric systems for determinations of analytes directly in capillaries of the skin without invasive sampling.
Solid-Phase ChemIstry-What
Is It?
The first solid-phase clinical tests, tablets added to urine samples, were introduced in the 1940s (3, 4) . These were largely supplanted in the 1950s and 60s by strips containing pieces of filter paper impregnated with the test chemicals (5, 6) . Today solid-phase tests include not only tablets and impregnated ifiter paper, but also colorimetric multi-layer films and electrochemical probes (7) . What, then, are solidphase chemistry tests? In general, solid-phase tests have the following characteristics. The chemicals used in the test are, at least in part, present in the form of dry chemicals contained in a carrier matrix. When the fluid sample is applied to the test, the dry chemicals dissolve in the aqueous portion of the sample and the analytical reaction proceeds. In some cases,not all of the chemicals dissolve in the sample, and a biphasic reaction occurson the surface of the solid phase. Solid-phase tests are supplied in individual test portions, to which the sample is generally applied directly. Typically, little or no preparation of the sample is required. The reagent is removed from its package, sample is applied, and the resulting chemical changes are interpreted. Components of solid-phase tests are generally more stable than the same chemicals in aqueous solutions.
The description of solid-phase chemistry tests can be expanded to say what solid-phase tests are not. First, the method of incorporating the chemicals is not limited. Virtually any method of dispensing the test chemicals that results in a dry, single-use package can be possible. Second, solidphase tests are not new. In their text on spot tests, Feigl and Anger (8) note the use by Runge of potassium iodide-starch paper to detect free chlorine in 1834 as well as the use by Schiff of silver carbonate-impregnated paper in 1859 to detect uric acid in urine. Third, the test results are not necessarily read by visual comparison with a color chart. The colorimetric changes are often read by reflectance spectroscopy. In some cases, the chemical changes monitored are electrochemical and not spectrophotometric. Fourth, the tests are not limited to analysis of any single body fluid.
An important aspect of solid-phase tests is the instrument used to measure the response of the solid-phase test to the sample. Such instruments can be much smaller than conventional instruments, even portable in some cases, because the format lends itself to mechanically simple measuring devices; in particular, measurement and transport of liquids can be avoided. These instruments can be used with little or no preparation or waiting period. Because-from the user's viewpoint-the test is composed of the reagent and the
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The single major characteristic of solid-phase tests is convenience for the user, which is most beneficial to the occasional test user in a decentralized or home setting. This convenience is not achieved by eliminating steps in the testing process; instead, the burden of performing the test steps is placed on the manufacturer, rather than the user. Alternatively, the convenience of the system comes from making the test more portable. Figure 1 shows the steps involved in the testing cycle, starting with the patient's health concerns and ending with treatment of the patient.
Opportunities for solid-phase tests will come from making any of these steps simpler for the user. The Figure also shows which steps are currently performed by the manufacturer of solid-phase tests or which steps are currently simplified by the use of solid-phase tests.
Applications of Solid-Phase Tests to New Areas of ClInIcal Chemistry
By making the tests more convenient, solid-phase tests can be performed in settings outside of the traditional laboratory.
The two settings of greatest potential use are decentralized professional laboratories (hospital wards, satellite facilities, or physicians' offices) and patients' homes.
The Decentralized Professional Laboratory
The reasons for testing in decentralized laboratories are a more efficient treatment of patients when test results are available rapidly and, in the case of physicians' offices laboratories,increased revenue for the practice (9) (10) (11) . The benefits of more efficient treatment can be shared by the patient, who may be spared trips to a central testing site or return trips to the physician's office. Also, office testing at the time of the first patient visit could detect problems in patients who choose not to comply with the physician's request for tests at a central laboratory.
Surveys of one type of decentralized laboratory, those in physicians' offices, have provided some information on the response to these benefits. In a telephone survey of 1660 randomly selected solo and group practices, only 12% reported owning a chemistry system (12) .
Surveys have also suggested that the concept of physicians' offices laboratories as single, homogeneous group of users is incorrect. Testing patients in offices of various specialists showed a uniformly high testing frequency only for urinalysis (13) Because the solid-phase instruments are mechanically simpler, they have the potential of being less expensive. Costs of whole-blood glucose meters have decreased severalfold from the time of their first introduction to today's current price of about $100. A major opportunity for solidphase tests in physicians' offices, then, is in the area of lowcost instrument systems.
In current systems, the manufacturer has performed the following steps (see Figure 1) : method selection, method optimization, purchase of materials, preparation of solutions, and dispensing of solution in aliquots. Because these systems are portable, solid-phase tests have simplified bringing the patient to the testing site. Whole-blood solidphase systems further simplify the steps for sample collection and sample preparation.
Two areas for further simplification shown in Figure 1 are calibration and verification of system performance. Needed today is either longer intervals between calibrations by the user or self-calibrating systems that require no actions by the user. Longer calibration intervals could result from improving the stability of both the reagents and the instrument. Self-calibration could result either from tight control of the reagent by the manufacturer to eliminate lot-to-lot differences or by encoding calibration information onto the reagent itself. In both cases, any changes in the reagents during storagemust be minimal, becausecalibration would be set at the time of manufacture. Self-calibration improves the convenience of the test by placing the burden of calibration upon the manufacturer.
Finally, another opportunity facing solid-phase tests is in the area of verification of system performance, or quality control. This particular area has been the topic of much discussion recently (9, 11, 14, 15) as well as consideration by regulatory agencies (14, 16, 17) . What is being sought are standards that will ensure that the quality of the result obtained in any setting is adequate for the clinical purposes of the test. Little agreement has been reached, however, on the definition of adequate quality or on the process of administering a program to ensure it.
Whatever the outcome of these discussions, clearly a major opportunity for solid-phase tests is the development of simple, convenient quality-control programs, perhaps integrated into the system itself. Such internal quality checks have been incorporated into fecal occult-blood tests for some time now and more recently into pregnancy tests.
Development of valid and convenient control systems will partly address the concerns over quality. Another aspect of quality is education of the user in the proper test operation and maintenance (18,19) . Unlike technicians in the central laboratory, the operator of the test in the physician's office may have little formal training in laboratory procedures. The opportunity (and challenge) for solid-phase tests in this area is to provide as simple as possible procedures for operating and maintenance. Alternative approaches, which could apply to any system, are periodic consultation by trained laboratory staff (20) or use of self-instructional packages (21) . With the recent advances in mmiaturation of electronic circuits, some of these features may be incorporated into the instrument itself.
Testing in the Home
Like the physicians' offices tests, the acceptability of the quality of home tests, most recently home blood-glucose tests, has been debated. Studies (22) (23) (24) have shown repeatedly that blood glucose measurements in the home are less accurate than the same determinations in the central laboratory. Yet the home glucose test has been recommended (25, 26) as an aid in developing patterns in the patient's blood glucose proffle, to assist in making day-to-day decisions about treatment, to assist in recognition of emergency situations, and to serve as an educational tool. This acceptance means that the accuracy of the test in the home setting, although less than the accuracy in a central laboratory, is adequate for the clinical purpose for which it is intended.
Extrapolation of this acceptance of home blood-glucose tests to other solid-phase home tests may be difficult, however. Development of clinical criteria for accuracy can be controversial. Although accuracy less than that attained in a central laboratory may be acceptable, opportunities for solid-phase home tests will be greatest when the accuracy of the test approaches that of the central laboratory.
Although current systems are acceptable for home bloodglucose monitoring, the endorsers recognize the need for simple, effective methods of quality control for these systems (25, 26) . Development of such quality-control systems are a large opportunity for solid-phase tests, in the home as well as in the physicians' offices.
Quality, however, includes all the steps aimed at validating the reliability and value of the result (27) . Ensuring that the result is adequately interpreted is also a part of quality, and this area is one in which solid-phase tests present an unusual opportunity. Consider the evidence that some diabetics will alter the results obtained from their home blood glucose test or will report results when no test was performed. This evidence includes a lack of correlation between the accuracy of result and the time since the user was trained with the system, the user's educational level, or the frequency of meter use (23). The authors of that study concluded that the lack of correlation implies noncompliance rather than inadequate learning.
In studies with meters that electronically stored the results (28) (29) (30) , there was considerable direct evidence that some diabetics either altered the result when recording it or recorded results when no test was performed. The incidence of fabricated results was greater in children than in adults  (29, 30) . Interestingly, when the fabricated results were discussed with the children, many speculated that the meter had malfunctioned, a behavior familiar to most parents.
Whatever the reasons are for the recording errors, such errors can affect the quality of the home test result. Solidphase systems have the opportunity to overcome this problem. Electronically recording the result in the home eliminates possible errors or bias in the user of the test. When such data are electronically retrieved by the physician, a more accurate representation of the patient's status may be obtained.
In summary, the experience with home blood-glucose testing has shown that home tests can be useful, even if less accurate than laboratory tests, provided that they meet the clinical needs. However, quality-control systems for such tests need to be improved, and patient compliance with the test can be a major factor in the success of such tests. The same issues should also apply to new solid-phase tests for the home market and will represent areas for improvement and opportunity.
A final point for consideration concerning new solid-phase tests for either physicians' officesor the home is the issue of what analytes require testing. In a discussion of home tests, Barnett (31) proposed that the home test meet the criteria of being simple to perform, simple to interpret, and relatively free of false reactions, and of providing information that leads to some sort of prompt action by the user. The first three issues can be addressed by solid-phase technology, but the last issue concerns the medical utility of the result itself, regardless of the method used to obtain it. Barnett concluded that glucose testing, in either urine or blood, and pregnancy testing meet these criteria, but that few, if any, tests for other analytes would.
Barnett's criteria most readily apply to tests designed to monitor therapy in the home, particularly if that therapy is either under the control of the patient or is potentially hazardous enough to merit immediate assessment. Determinations of blood and urine glucose in diabetics are performed to monitor therapy with insulin; because these values can vary dramatically over short periods, frequent measurements of them are desirable. The extent of further opportunities in solid-phase home tests depends on the degree to which other analytes meet these criteria.
New TechnIques In Solid-Phase Chemistry Tests
Published accounts of new solid-phase chemical techniques can be roughly divided into three groups: noncolonmetric sensors, miniature probes, and noninvasive methods. Additional discussions of these approaches are presented in companion papers in this conference.
Noncolori metric sensors generally refer to potentiometric readings. The technique has been used for solid-phase tests for ions (32) and other analytes (33, 34). Some systems use disposable ion-selective electrodes in the reagent card, while others involve devices capable of multiple uses. The instruments measure the electrochemical responses to the analytes instead of the colorimetric responses.
Probes. The advantage of electrochemical systems is that they can be made quite small, converting the system into a "probe." Miniaturization will be more difficult with colorimetric systems. Probes offer the user two advantages: small sample size for in vitro tests, and the possibility of in vivo use. With miniature probes, one may be able to make several simultaneous measurements on very small drops of blood, which will simplify the sample collection and sample preparation steps (see Figure 1) . One current system does simultaneous measurements (34).
The major advantage obtained from in vivo probes is continuous measurement, which goes beyond the traditional testing cycle shown in the Figure. Continuous measurements provide the physician with an integrated estimate of analyte concentrations in the body over time, information that may have various degrees of clinical utility. An external probe system for continuous monitoring of blood glucose and control of insulin infusion was described in 1978 (35) . Adaptation of the current probe technology for in vivo use faces problems in areas of biocompatibility, calibration, sensitivity, selectivity, and precision (36). Biocompatibility has two parts. First, the probe must not harm the body; second, the body must not alter the performance of the probe. Calibration stability can be limited by in vivo alterations of the probe's performance as well as by electrical drift in the instrument.
Finally, the possibility of noninvasive measurements is being explored. Developmental work on a system for noninvasive measurement of blood glucose across the buccal membrane of the cheek has been noted (37) . A noninvasive technique can simplify the steps involved with sample collection and preparation (Figure 1) , as well as eliminate the pain involved in obtaining a sample of blood. The system mentioned reportedly involved immobilized enzymes in membranes placed against the inside of the cheek.
An even larger departure from current systems are those that do not use any reagents, but instead measure the analyte in the capillaries of the skin directly by spectrophotometry (38) . Such systems are "reagent-less" and overcome the biocompatibility problems seen with membrane probes. At present, the problems with these systems involve separating the spectrophotometric changes caused by the analyte concentration from those from other sources. if solved, this approach could provide convenient tests with few, if any, disposable components.
In conclusion: new opportunities for solid-phase reagents exist where they can simplify or improve the steps in the testing cycle (Figure 1 ). When the systems are made smaller and more convenient, opportunities still exist to improve such steps as recording the result and interpreting the result, as in blood glucose systems that electronically record the results. New technologies that can further simplify testing are appearing, but the final success of these technologies will be determined by how well they meet the needs of the users.
